TY - JOUR
T1 - Sequence γ377-395(P2), but not γ190-202(P1), is the binding site for the αMI-domain of integrin αMβ2 in the αC-domain of fibrinogen
AU - Ugarova, Tatiana P.
AU - Lishko, Valeryi K.
AU - Podolnikova, Nataly P.
AU - Okumura, Nobuo
AU - Merkulov, Sergei M.
AU - Yakubenko, Valentin P.
AU - Yee, Vivien C.
AU - Lord, Susan T.
AU - Haas, Thomas A.
PY - 2003/8/12
Y1 - 2003/8/12
N2 - The interaction between the leukocyte integrin αMβ2 (CD11b/CD18, Mac-1, CR3) and fibrinogen mediates the recruitment of phagocytes during the inflammatory response. Previous studies demonstrated that peptides P2 and P1, duplicating γ377-395 and γ190-202 sequences in the γC domain of fibrinogen, respectively, blocked the fibrinogen-binding function of αMβ2, implicating these sequences as possible binding sites for αMβ2. To determine the role of these sequences in integrin binding, recombinant wild-type and mutant γC domains were prepared, and their interactions with the αMI-domain, a ligand recognition domain within αMβ2, were tested. Deletion of γ383-411 (P2-C) and γ377-411 produced γC mutants which were defective in binding to the αMI-domain. In contrast, alanine mutations of several residues in P1 did not affect αMI-domain binding, and simultaneous mutations in P1 and deletion of P2 did not decrease the binding function of γC further. Verifying the significance of P2, inserting P2-C and the entire P2 into the homologous position of the βC-domain of fibrinogen imparted the higher αMI-domain binding ability to the chimeric proteins. To further define the molecular requirements for the P2-C activity, synthetic peptides derived from P2-C and a peptide array covering P2-C have been analyzed, and a minimal recognition motif was localized to γ390NRLTIG395. Confirming a critical role of this sequence, the cyclic peptide NRLTIG retained full activity inherent to P2-C, with Arg and Leu being important residues. Thus, these data demonstrate the essential role of the P2, but not P1, sequence for binding of γC by the αMI-domain and suggest that the adhesive function of P2 depends on the minimal recognition motif NRLTIG.
AB - The interaction between the leukocyte integrin αMβ2 (CD11b/CD18, Mac-1, CR3) and fibrinogen mediates the recruitment of phagocytes during the inflammatory response. Previous studies demonstrated that peptides P2 and P1, duplicating γ377-395 and γ190-202 sequences in the γC domain of fibrinogen, respectively, blocked the fibrinogen-binding function of αMβ2, implicating these sequences as possible binding sites for αMβ2. To determine the role of these sequences in integrin binding, recombinant wild-type and mutant γC domains were prepared, and their interactions with the αMI-domain, a ligand recognition domain within αMβ2, were tested. Deletion of γ383-411 (P2-C) and γ377-411 produced γC mutants which were defective in binding to the αMI-domain. In contrast, alanine mutations of several residues in P1 did not affect αMI-domain binding, and simultaneous mutations in P1 and deletion of P2 did not decrease the binding function of γC further. Verifying the significance of P2, inserting P2-C and the entire P2 into the homologous position of the βC-domain of fibrinogen imparted the higher αMI-domain binding ability to the chimeric proteins. To further define the molecular requirements for the P2-C activity, synthetic peptides derived from P2-C and a peptide array covering P2-C have been analyzed, and a minimal recognition motif was localized to γ390NRLTIG395. Confirming a critical role of this sequence, the cyclic peptide NRLTIG retained full activity inherent to P2-C, with Arg and Leu being important residues. Thus, these data demonstrate the essential role of the P2, but not P1, sequence for binding of γC by the αMI-domain and suggest that the adhesive function of P2 depends on the minimal recognition motif NRLTIG.
UR - http://www.scopus.com/inward/record.url?scp=0042573729&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042573729&partnerID=8YFLogxK
U2 - 10.1021/bi034057k
DO - 10.1021/bi034057k
M3 - Article
C2 - 12899623
AN - SCOPUS:0042573729
SN - 0006-2960
VL - 42
SP - 9365
EP - 9373
JO - Biochemistry
JF - Biochemistry
IS - 31
ER -